Metal‐Organic Complex‐Engineered Artificial Metalloenzymes With Synergistic Site and Cascade ROS Elimination to Treat Cerebral Ischemic‐Reperfusion Injury
Angewandte Chemie International Edition · 22.06.2026 · 65 (26)
DOI: 10.1002/anie.1441985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 06.05.2026. Verfasst von Chan Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University …. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Reperfusion Injury, Brain Ischemia, Coordination Complexes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Ischemic stroke is a fatal cerebrovascular disease, and reperfusion, the primary approach for restoring blood supply, can lead to significant oxidative stress and subsequent damage to the cerebrovascular system. Developing strong antioxidant agents could be a solution, but it remains a Herculean challenge. Herein, inspired by the three‐dimensional coordination structures and active center of natural Mn‐superoxide dismutase, coupled with the synergistic monoatom/cluster sites found in antioxidases, we propose the de novo design of Mn‐organic complex‐supported Ru clusters (MnCP‐Ru) to function as an artificial metalloenzyme for cascade elimination of reactive oxygen species (ROS), aimed at protecting against cerebral ischemic‐reperfusion injury. Our studies show that Mn‐organic ligands increase the electron density of Ru clusters, thereby improving their binding to oxygen species and resulting in effective, cascade‐like antioxidase activities. Accordingly, the MnCP‐Ru can reduce the number of apoptotic neurons by attenuating ROS‐induced cell damage and exert powerful anti‐inflammatory effects by inhibiting lipid peroxidation, microglial and astrocyte activation in brain tissues, thus leading to powerful protection and repair of cerebral ischemia‐reperfusion injury. We believe the MnCP‐Ru biocatalyst, with its synergistic sites and cascade ROS elimination, offers effective antioxidative performance, paving the way for developing materials to treat ischemic‐reperfusion injury and other oxidative stress‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, China.
- College of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu, China.
- School of Pharmacy and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, China.
- College of Food and Brewing Engineering, Sichuan University of Science & Engineering, Yibin, China.
- Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
ORCID-Profile: Xiaolin Wang, Qiu Chen, Chong Cheng
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Sichuan Science and Technology Program
- Macau Science and Technology Development Fund
Zitieren
APA
Zhu, C., Wang, T., Xing, Z., Gao, Y., Wang, X., Cheng, L., Mu, S., Chen, Q., & Cheng, C. (2026). Metal‐Organic Complex‐Engineered Artificial Metalloenzymes With Synergistic Site and Cascade ROS Elimination to Treat Cerebral Ischemic‐Reperfusion Injury. Angewandte Chemie International Edition, 65(26). https://doi.org/10.1002/anie.1441985
Vancouver
Zhu C, Wang T, Xing Z, Gao Y, Wang X, Cheng L, et al. Metal‐Organic Complex‐Engineered Artificial Metalloenzymes With Synergistic Site and Cascade ROS Elimination to Treat Cerebral Ischemic‐Reperfusion Injury. Angewandte Chemie International Edition. 2026;65(26). doi:10.1002/anie.1441985
BibTeX
@article{Zhu2026,
author = {Zhu, Chan and Wang, Ting and Xing, Zhenyu and Gao, Yang and Wang, Xiaolin and Cheng, Liang and Mu, Shengdong and Chen, Qiu and Cheng, Chong},
title = {Metal‐Organic Complex‐Engineered Artificial Metalloenzymes With Synergistic Site and Cascade ROS Elimination to Treat Cerebral Ischemic‐Reperfusion Injury},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {26},
doi = {10.1002/anie.1441985}
}
EUVIMED